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ABSTRACT
Pleural tuberculosis occurs in 30% of patients with tuberculosis, and the percentage of patients with 
tuberculosis pleural effusions is comparable to human immunodefi ciency virus HIV-positive and 
HIV-negative individuals, although pleural tuberculosis is rare in HIV-positive patients with CD4+ 
counts < 200 cells/mm³. Pleural tuberculosis in HIV-positive patients is likely to happen in young 
patients, and is more frequent in intravenous drug abusers, with more acid-fast bacilli identifi able 
in pleural tissue. We report a rare case of pleural tuberculosis in a severely immunosuppressed HIV-
positive patient, presented as two parasternum pleural-cutaneous fi stula.
Keywords: pleural tuberculosis, parasternum pleural-cutaneous fi stula, severely immunosupressed 
HIV-positive patient.
[Braz J Infect Dis 2010;14(2):183-185]©Elsevier Editora Ltda.
INTRODUCTION
Pleural tuberculosis occurs in 30% of pa-
tients with tuberculosis, and the percentage 
of patients with tuberculosis pleural effu-
sions is comparable to human immunodefi-
ciency virus HIV-positive and HIV-negative 
individuals, although pleural tuberculosis 
is rare in HIV-positive patients with CD4+ 
counts < 200 cells/mm³.1
HIV infection changes the clinical pres-
entation of tuberculosis infection, favoring 
atypical radiographs and extrapulmonary 
involvement. In a previous study, pleural tu-
berculosis in HIV-positive patients was more 
common in younger patients, who were in-
travenous drug abusers, had significantly 
more acid-fast bacilli identifiable in pleural 
tissue and in sputum cultures.2
We examined a rare case of parasternum 
pleural-cutaneous fistula from pleural tu-
berculosis in a HIV-positive patient with a 
CD4+ count of 11 cells/mm³.
 
CASE REPORT
A 33-year-old male patient, from the city of 
São Paulo, was sent to the Clinical Emergency 
Department of the Conjunto Hospitalar do 
Mandaqui due to weight loss of 19 kilograms, 
asthenia, weakness, cough, daily vespertine 
fever, night sweating, abdominal pain, and 
a progressively worsening dyspnea in the 
previous three weeks. The patient was HIV-
positive for about 14 years, was an intrave-
nous drug user, had started the antiretroviral 
therapy five years before this admission, and 
had abandoned the antiretroviral therapy. 
His medical history included a pulmonary 
tuberculosis infection treated appropriately 
in 2004; he was a chronic hepatitis B virus 
carrier and had chronic asymptomatic hepa-
titis C virus.
At admission, the patient was thin and 
had a consumptive status, oral lesions com-
patible with Candida albicans infection, non-
specific abdominal pain and absent pulmo-
nary murmurs at the inferior two-thirds of 
the left hemithorax. Diagnostic hypothesis 
were AIDS, bacterial pneumonia, pulmonary 
tuberculosis, or Pneumocystis jiroveci pneu-
monia with pleural effusion. Initial exams 
included hemogram, electrolytes, hepatic 
and canalicular enzymes, coagulation tests, 
serum albumin, sputum, and blood cultures, 
which resulted negative for infection.
His HIV viral load had increased by ap-
proximately one log, and his CD4+ count 
had decreased substantially in the last two 
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years before this admission, corresponding to transitory 
non-adherence to antiretroviral therapy (Table 1).
As the initial clinical symptoms were suggestive of 
pulmonary tuberculosis in a severely immunosuppressed 
HIV-positive patient, sputum samples have been collected, 
searching for acid-fast bacilli related to pulmonary infec-
tion, but in all samples, no bacteria or acid-fast bacilli has 
been identifi ed.
A month after his admission, the patient presented a non 
tender mass of elastic consistency adhered to deep planes in 
the left parasternum region, below healthy skin, with no point 
of ﬂ uctuation or local warmth. Ultrasonographic evaluation 
revealed heterogeneous density containing liquid and dense 
material with septa, without clear cleavage plane in relation 
to the intercostal muscles, measuring 48 x 42 mm. Thoracic 
surgeons have performed puncture and aspiration of the 
mass, and the aspirate analysis revealed acid-fast bacilli in 
great amount (+++), with no other microbiologic elements 
suggestive of infection, except Mycobacterium tuberculo-
sis. Patient received the following prescription: rifampicin, 
isoniazid, pyrazinamide, and ethambutol. Seven days after 
the fi rst evaluation of the parasternum mass, another two 
thoracic masses had arisen in the intercostal spaces of left 
parasternum region, with irregular borders, liquid material, 
debris, and septations, measuring 40 x 24 mm and 25 x 13 
mm, also aspirated. Both pleural aspirates revealed lym-
phocytic predominance, high levels of DHL (1,798 and 960 
mg/dL), presence of high parasternum quantity of acid-fast 
bacilli (more than fi ve bacilli per fi eld) and negative bacte-
rial cultures.
A thoracic CT scan has been done for a detailed anal-
ysis of the masses and their anatomic relation with the 
lungs, pleura, and subcutaneous thoracic tissue and re-
vealed a clear dissemination of the masses from the left 
pleura to the muscular thoracic layers and to the subcu-
taneous tissue (Figures 1 and 2). We diagnosed pleural 
tuberculosis in a severely immunosupressed HIV-positive 
patient.
Table 1. Viral load, CD4 counting, CD8 counting, and CD4/CD8 ratio
Date VL (copies/mm³) Log CD4 (cells/mm³) CD8 (cells/mm³) CD4/CD8
April 11 2006 ----- ----- 11 93 0.12
February 21 2006 ----- ----- 11 120 0.09
June 20 2005 15,100 4,179 121 926 0.13
March 23 2005 1,140 3,057 220 902 0.24
September 14 2004 ----- ----- 35 218 0.16
August 27 2004 ----- ----- 8 75 0.11
November 27 2002 ----- ----- 301 794 0.38
August 05 2002 ----- ----- 142 419 0.34
Figure 1: Thoracic CT scan of parasternum masses, showing left 
pleural effusion and evident continuity between the pleural space and 
the thoracic wall.
Figure 2: Thoracic scan showing tracheal deviation to the right, and 
predominance of left pleural effusion.
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DISCUSSION
Pleural tuberculosis and HIV infection are strongly 
associated in HIV-infected patients. The pathogenesis of 
HIV-associated pleural tuberculosis involves direct bacterial 
invasion of pleural space, and the loss of immunity due to 
tuberculosis in HIV infection result from CD4+ Tcell deple-
tion and reduction of antigen-specifi c cytokines responses, 
resulting in an uncontrolled mycobacterium replication, de-
spite of the elevated levels of interferon-gamma and tumor 
necrosis factor-alpha.3 
In this case report, among all clinical clues of extra pul-
monary tuberculosis.4 the patient had an exudative pleural 
effusion, with lymphocytic predominance, negative bacterial 
cultures, and HIV infection. Moreover, the caseous-purulent 
aspect of the fi stulized material, associated with the hetero-
genic density at the ultrasonografi c evaluation, as reported 
elsewhere in the literature5 are typical evidence of pleural 
tuberculosis.
This patient presented four of the independent risk fac-
tors for pleural tuberculosis:6 history of liver disease (hepa-
titis B and C infection), Mycobacterium tuberculosis culture 
negative in sputum, chest pain, and presence of symptoms 
for less than 60 days. Additional suggestive symptoms were 
dyspnea and abdominal pain, more frequent in HIV-infect-
ed patients with pleural tuberculosis than with pulmonary 
tuberculosis. 
Antituberculous therapy minimizes the morbimortality 
associated with tuberculosis infection and must be initiated 
empirically in most cases, once negative smear form acid-
fast bacillus, lack of granulomas in HIV-infected patients, 
and negative cultures to Mycobacterium tuberculosis are not 
rare in severely immunosuppressed HIV-infected patients 
with pleural tuberculosis. 
Even with the empirical introduction of antitubercu-
lous therapy, the mortality rate in HIV-patients remains 
elevated.
Treatment with rifampicin, isoniazid, pyrazinamide, and 
ethambutol had been continued, and, after two weeks of 
treatment, one of the masses fi stulized to the skin, exterior-
izing a yellow, caseous-purulent material, rich in acid-fast 
bacilli. Despite introduction of the adequate treatment for 
pleural tuberculosis, the patient died after 32 days of treat-
ment.
 
CONCLUSION
Severely immunosuppressed HIV-positive patients usu-
ally present pleural tuberculosis at a younger age than HIV-
negative patients. Once their immune response is impaired, 
when CD4+ count is < 200 cells/mm³, they do not present 
granulomas and have higher quantity of acid-fast bacilli 
identifi ed in both pleural effusion and pleural tissue. In this 
subgroup of patients, pleural tuberculosis indicates a severe 
immunosuppression caused by HIV infection and, despite 
of the prompt introduction of correct treatment against tu-
berculosis, the response may be too late and the patient may 
not survive.
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